<?xml version='1.0' encoding='utf-8'?>
<document id="21672627"><sentence text="Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models."><entity charOffset="36-45" id="DDI-PubMed.21672627.s1.e0" text="ascorbate" /><entity charOffset="96-107" id="DDI-PubMed.21672627.s1.e1" text="glutathione" /><pair ddi="false" e1="DDI-PubMed.21672627.s1.e0" e2="DDI-PubMed.21672627.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s1.e0" e2="DDI-PubMed.21672627.s1.e1" /></sentence><sentence text="Two popular complementary, alternative, and integrative medicine therapies, high-dose intravenous ascorbic acid (AA) and intravenous glutathione (GSH), are often coadministered to cancer patients with unclear efficacy and drug-drug interaction"><entity charOffset="98-111" id="DDI-PubMed.21672627.s2.e0" text="ascorbic acid" /><entity charOffset="113-115" id="DDI-PubMed.21672627.s2.e1" text="AA" /><entity charOffset="133-144" id="DDI-PubMed.21672627.s2.e2" text="glutathione" /><entity charOffset="146-149" id="DDI-PubMed.21672627.s2.e3" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e0" e2="DDI-PubMed.21672627.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e0" e2="DDI-PubMed.21672627.s2.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e0" e2="DDI-PubMed.21672627.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e0" e2="DDI-PubMed.21672627.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e1" e2="DDI-PubMed.21672627.s2.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e1" e2="DDI-PubMed.21672627.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e1" e2="DDI-PubMed.21672627.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e2" e2="DDI-PubMed.21672627.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s2.e2" e2="DDI-PubMed.21672627.s2.e3" /></sentence><sentence text=" In this study we provide the first survey evidence for clinical use of iv GSH with iv AA"><entity charOffset="87-89" id="DDI-PubMed.21672627.s3.e0" text="AA" /><entity charOffset="75-77" id="DDI-PubMed.21672627.s3.e1" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s3.e1" e2="DDI-PubMed.21672627.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s3.e1" e2="DDI-PubMed.21672627.s3.e0" /></sentence><sentence text=" To address questions of efficacy and drug-drug interaction, we tested 10 cancer cell lines with AA, GSH, and their combination"><entity charOffset="97-99" id="DDI-PubMed.21672627.s4.e0" text="AA" /><entity charOffset="101-103" id="DDI-PubMed.21672627.s4.e1" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s4.e0" e2="DDI-PubMed.21672627.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s4.e0" e2="DDI-PubMed.21672627.s4.e1" /></sentence><sentence text=" The results showed that pharmacologic AA induced cytotoxicity in all tested cancer cells, with IC(50) less than 4 mM, a concentration easily achievable in humans"><entity charOffset="39-41" id="DDI-PubMed.21672627.s5.e0" text="AA" /></sentence><sentence text=" GSH reduced cytotoxicity by 10-95% by attenuating AA-induced H(2)O(2) production"><entity charOffset="62-70" id="DDI-PubMed.21672627.s6.e0" text="H(2)O(2)" /><entity charOffset="51-58" id="DDI-PubMed.21672627.s6.e1" text="AA" /><entity charOffset="1-8" id="DDI-PubMed.21672627.s6.e2" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s6.e2" e2="DDI-PubMed.21672627.s6.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s6.e2" e2="DDI-PubMed.21672627.s6.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s6.e2" e2="DDI-PubMed.21672627.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s6.e1" e2="DDI-PubMed.21672627.s6.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s6.e1" e2="DDI-PubMed.21672627.s6.e0" /></sentence><sentence text=" Treatment in mouse pancreatic cancer xenografts showed that intraperitoneal AA at 4 g/kg daily reduced tumor volume by 42%"><entity charOffset="77-79" id="DDI-PubMed.21672627.s7.e0" text="AA" /></sentence><sentence text=" Addition of intraperitoneal GSH inhibited the AA-induced tumor volume reduction"><entity charOffset="47-48" id="DDI-PubMed.21672627.s8.e0" text="AA" /><entity charOffset="29-30" id="DDI-PubMed.21672627.s8.e1" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s8.e1" e2="DDI-PubMed.21672627.s8.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s8.e1" e2="DDI-PubMed.21672627.s8.e0" /></sentence><sentence text=" Although all treatments (AA, GSH, and AA+GSH) improved survival rate, AA+GSH inhibited the cytotoxic effect of AA alone and failed to provide further survival benefit"><entity charOffset="26-28" id="DDI-PubMed.21672627.s9.e0" text="AA" /><entity charOffset="39-41" id="DDI-PubMed.21672627.s9.e1" text="AA" /><entity charOffset="71-73" id="DDI-PubMed.21672627.s9.e2" text="AA" /><entity charOffset="112-114" id="DDI-PubMed.21672627.s9.e3" text="AA" /><entity charOffset="30-32" id="DDI-PubMed.21672627.s9.e4" text="GSH" /><entity charOffset="42-44" id="DDI-PubMed.21672627.s9.e5" text="GSH" /><entity charOffset="74-76" id="DDI-PubMed.21672627.s9.e6" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e4" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e5" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e0" e2="DDI-PubMed.21672627.s9.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e4" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e5" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e4" e2="DDI-PubMed.21672627.s9.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e1" e2="DDI-PubMed.21672627.s9.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e1" e2="DDI-PubMed.21672627.s9.e5" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e1" e2="DDI-PubMed.21672627.s9.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e1" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e1" e2="DDI-PubMed.21672627.s9.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e5" e2="DDI-PubMed.21672627.s9.e5" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e5" e2="DDI-PubMed.21672627.s9.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e5" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e5" e2="DDI-PubMed.21672627.s9.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e2" e2="DDI-PubMed.21672627.s9.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e2" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e2" e2="DDI-PubMed.21672627.s9.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e6" e2="DDI-PubMed.21672627.s9.e6" /><pair ddi="false" e1="DDI-PubMed.21672627.s9.e6" e2="DDI-PubMed.21672627.s9.e3" /></sentence><sentence text=" These data confirm the pro-oxidative anti-cancer mechanism of pharmacologic AA and suggest that AA and GSH administered together provide no additional benefit compared with AA alone"><entity charOffset="77-79" id="DDI-PubMed.21672627.s10.e0" text="AA" /><entity charOffset="97-99" id="DDI-PubMed.21672627.s10.e1" text="AA" /><entity charOffset="174-176" id="DDI-PubMed.21672627.s10.e2" text="AA" /><entity charOffset="104-106" id="DDI-PubMed.21672627.s10.e3" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e0" e2="DDI-PubMed.21672627.s10.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e0" e2="DDI-PubMed.21672627.s10.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e0" e2="DDI-PubMed.21672627.s10.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e0" e2="DDI-PubMed.21672627.s10.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e1" e2="DDI-PubMed.21672627.s10.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e1" e2="DDI-PubMed.21672627.s10.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e1" e2="DDI-PubMed.21672627.s10.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e3" e2="DDI-PubMed.21672627.s10.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s10.e3" e2="DDI-PubMed.21672627.s10.e2" /></sentence><sentence text=" There is an antagonism between ascorbate and glutathione in treating cancer, and therefore iv AA and iv GSH should not be coadministered to cancer patients on the same day"><entity charOffset="32-41" id="DDI-PubMed.21672627.s11.e0" text="ascorbate" /><entity charOffset="46-57" id="DDI-PubMed.21672627.s11.e1" text="glutathione" /><entity charOffset="95-105" id="DDI-PubMed.21672627.s11.e2" text="AA" /><entity charOffset="105-115" id="DDI-PubMed.21672627.s11.e3" text="GSH" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e0" e2="DDI-PubMed.21672627.s11.e0" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e0" e2="DDI-PubMed.21672627.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e0" e2="DDI-PubMed.21672627.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e0" e2="DDI-PubMed.21672627.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e1" e2="DDI-PubMed.21672627.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e1" e2="DDI-PubMed.21672627.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e1" e2="DDI-PubMed.21672627.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e2" e2="DDI-PubMed.21672627.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21672627.s11.e2" e2="DDI-PubMed.21672627.s11.e3" /></sentence><sentence text="" /></document>